BioVie Inc (BIVI)
0.46
-0.02
(-5.00%)
USD |
NASDAQ |
May 23, 16:00
0.463
0.00 (0.00%)
Pre-Market: 08:10
BioVie Cash from Operations (Quarterly): -5.852M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.852M |
| December 31, 2023 | -5.910M |
| September 30, 2023 | -12.18M |
| June 30, 2023 | -11.29M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -8.009M |
| September 30, 2022 | -9.220M |
| June 30, 2022 | -5.865M |
| March 31, 2022 | -5.885M |
| December 31, 2021 | -4.706M |
| September 30, 2021 | -2.535M |
| June 30, 2021 | -7.008M |
| March 31, 2021 | -1.042M |
| December 31, 2020 | -1.319M |
| September 30, 2020 | -1.084M |
| June 30, 2020 | -0.36M |
| March 31, 2020 | -0.4014M |
| December 31, 2019 | -0.2759M |
| September 30, 2019 | -0.5909M |
| June 30, 2019 | -0.6317M |
| March 31, 2019 | -0.6589M |
| December 31, 2018 | -0.7691M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.4419M |
| June 30, 2018 | -0.2093M |
| March 31, 2018 | -0.0487M |
| December 31, 2017 | -0.1599M |
| September 30, 2017 | -0.2034M |
| June 30, 2017 | -0.1252M |
| March 31, 2017 | -0.2687M |
| December 31, 2016 | -0.1017M |
| September 30, 2016 | -0.128M |
| June 30, 2016 | -0.1194M |
| March 31, 2016 | -0.0163M |
| December 31, 2015 | -0.016M |
| September 30, 2015 | -0.002M |
| June 30, 2015 | -0.0111M |
| March 31, 2015 | -0.0095M |
| December 31, 2014 | -0.0301M |
| September 30, 2014 | -0.0147M |
| June 30, 2014 | -0.0124M |
| March 31, 2014 | -0.0616M |
| December 31, 2013 | -0.039M |
| September 30, 2013 | -0.0598M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.18M
Minimum
Sep 2023
-0.2759M
Maximum
Dec 2019
-4.795M
Average
-5.279M
Median
Cash from Operations (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | -1.626M |
| Precision BioSciences Inc | -18.98M |
| Cardiff Oncology Inc | -7.74M |
| Jaguar Health Inc | -7.047M |
| Entero Therapeutics Inc | -3.747M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 15.98M |
| Free Cash Flow | -35.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1306 |
| Free Cash Flow Yield | -196.4% |